Modulating the tumor microenvironment via oncolytic virus and PI3K inhibition synergistically restores immune checkpoint therapy response in PTEN-deficient glioblastoma.

ABSTRACT:

SUBMITTER: Xing F 

PROVIDER: S-EPMC8316409 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature